Xiaofeng Niu

3.2k total citations
118 papers, 2.6k citations indexed

About

Xiaofeng Niu is a scholar working on Molecular Biology, Pharmacology and Immunology. According to data from OpenAlex, Xiaofeng Niu has authored 118 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 27 papers in Pharmacology and 27 papers in Immunology. Recurrent topics in Xiaofeng Niu's work include Berberine and alkaloids research (17 papers), Natural product bioactivities and synthesis (16 papers) and Pharmacological Effects of Natural Compounds (13 papers). Xiaofeng Niu is often cited by papers focused on Berberine and alkaloids research (17 papers), Natural product bioactivities and synthesis (16 papers) and Pharmacological Effects of Natural Compounds (13 papers). Xiaofeng Niu collaborates with scholars based in China, Hong Kong and United States. Xiaofeng Niu's co-authors include Weifeng Li, Ting Fan, Huimin Huang, Wenbing Zhi, Huan Yao, Qingli Mu, Zehong He, Xiumei Wang, Jinmeng Zhao and Huani Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and PLANT PHYSIOLOGY.

In The Last Decade

Xiaofeng Niu

114 papers receiving 2.6k citations

Peers

Countries citing papers authored by Xiaofeng Niu

Since Specialization

Citations

This map shows the geographic impact of Xiaofeng Niu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaofeng Niu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaofeng Niu more than expected).

Fields of papers citing papers by Xiaofeng Niu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaofeng Niu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaofeng Niu. The network helps show where Xiaofeng Niu may publish in the future.

Co-authorship network of co-authors of Xiaofeng Niu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaofeng Niu. A scholar is included among the top collaborators of Xiaofeng Niu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaofeng Niu. Xiaofeng Niu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploring molecular mechanism of Panlongqi Tablet (PLQT) against RA: Integrated network pharmacology, molecular docking and experiment validation 2024 ·International Immunopharmacology ·(unknown), Jinjin Yu, (unknown), Lili Zhou, Xinyao Liu, (unknown), (unknown), (unknown), Xinya Zhang, Yang Liu, Dezhu Zhang, Junlong Meng, (unknown), Weifeng Li, Xiaofeng Niu	0
2	Glycoprotein from selenium-enriched yam activates immune cells and enhances intestinal immunity via the NF-κB signaling pathway 2024 ·Food Bioscience ·Siqi Wang, Jinjin Yu, (unknown), (unknown), Lingyi Liu, (unknown), (unknown), (unknown), (unknown), (unknown), Weifeng Li, Xiaofeng Niu	1
3	Rapid analysis of the chemical constituents in Qiangli Dingxuan tablets using ultra‐performance liquid chromatography coupled with quadrupole time‐of‐flight tandem mass spectrometry 2024 ·Journal of Separation Science ·(unknown), Yaxuan Wang, Wenjun Sun, Xiaohui Li, Yunzhe Li, Lu Bai, Xiaofeng Niu	4
4	Harmine ameliorates CCl4-induced acute liver injury through suppression of autophagy and inflammation 2024 ·International Immunopharmacology ·(unknown), Wenqi Li, Qing Yao, Yang Liu, Jinjin Yu, Lulu Zang, Siqi Wang, Lili Zhou, (unknown), (unknown), Weifeng Li, Xiaofeng Niu	11
5	Abstract 183: A novel bispecific antibody macrophage engager (BiME) designed for the treatment of solid tumors 2024 ·Cancer Research ·Dawei Sun, Haixia Jiang, (unknown), (unknown), (unknown), (unknown), Quan Qiu, Yanfen Hu, Yingchao Liu, Xiaoli Guo, Xiaofeng Niu, Hongtao Lu	1
6	Solid fuel derived PM2.5 induced oxidative stress and according cytotoxicity in A549 cells: The evidence and potential neutralization by green tea 2022 ·Environment International ·Jian Sun, Jinjin Yu, Xinyi Niu, Xinya Zhang, Lili Zhou, Xinyao Liu, Bin Zhang, Kun He, Xiaofeng Niu, Kin‐Fai Ho, Junji Cao, Zhenxing Shen	16
7	Tectoridin exhibits anti-rheumatoid arthritis activity through the inhibition of the inflammatory response and the MAPK pathway in vivo and in vitro 2022 ·Archives of Biochemistry and Biophysics ·Qiuxia Huang, Xin Xiao, Jinjin Yu, (unknown), (unknown), Yang Liu, (unknown), (unknown), Dezhu Zhang, Xiaofeng Niu, Weifeng Li	14
8	Imperatorin reduces the inflammatory response of atherosclerosis by regulating MAPKs signaling pathway in vivo and in vitro 2020 ·International Immunopharmacology ·Wenqi Li, Jinjin Yu, Xin Xiao, Lulu Zang, Yajie Yang, (unknown), Qiuxia Huang, Xiaofeng Niu, Weifeng Li	10
9	The inhibitory effect of (−)-Epicatechin gallate on the proliferation and migration of vascular smooth muscle cells weakens and stabilizes atherosclerosis 2020 ·European Journal of Pharmacology ·Weifeng Li, Jinjin Yu, Xin Xiao, Wenqi Li, Lulu Zang, (unknown), Dezhu Zhang, Xiaofeng Niu	16
10	Anti-inflammatory effect of Yam Glycoprotein on lipopolysaccharide-induced acute lung injury via the NLRP3 and NF-κB/TLR4 signaling pathway 2019 ·International Immunopharmacology ·Xiaofeng Niu, Lulu Zang, Wenqi Li, Xin Xiao, Jinjin Yu, Qing Yao, Jinmeng Zhao, (unknown), Zhen Hu, Weifeng Li	38
11	Pathological changes in Sertoli cells and dysregulation of divalent metal transporter 1 with iron responsive element in the testes of idiopathic azoospermia patients 2017 ·Andrologia ·Tao Jing, (unknown), (unknown), Jiao Zhao, Xiaofeng Niu, (unknown)	11
12	Preparation, Characterization and Anti-Ulcer Efficacy of Sanguinarine Loaded Solid Lipid Nanoparticles 2017 ·Pharmacology ·Qing Sun, Weifeng Li, Huani Li, Xiumei Wang, Yu Wang, Xiaofeng Niu	13
13	Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro 2017 ·Inflammation ·Xiaofeng Niu, Fang Liu, Weifeng Li, Wenbing Zhi, Hailin Zhang, Xiumei Wang, Zehong He	29
14	Protective Effects of Nobiletin Against Endotoxic Shock in Mice Through Inhibiting TNF-α, IL-6, and HMGB1 and Regulating NF-κB Pathway 2016 ·Inflammation ·Weifeng Li, Xiumei Wang, Xiaofeng Niu, Hailin Zhang, Zehong He, Yu Wang, Wenbing Zhi, Fang Liu	29
15	Anti-ulcerogenic effect of cavidine against ethanol-induced acute gastric ulcer in mice and possible underlying mechanism 2016 ·International Immunopharmacology ·Weifeng Li, Xiumei Wang, Hailin Zhang, Zehong He, Wenbing Zhi, Fang Liu, Yu Wang, Xiaofeng Niu	60
16	Protective effects of Isofraxidin against lipopolysaccharide-induced acute lung injury in mice 2015 ·International Immunopharmacology ·Xiaofeng Niu, Yu Wang, Weifeng Li, Qingli Mu, Huani Li, Huan Yao, Hailin Zhang	59
17	Esculentic acid, a novel and selective COX-2 inhibitor with anti-inflammatory effect in vivo and in vitro 2014 ·European Journal of Pharmacology ·Xiaofeng Niu, Qingli Mu, Weifeng Li, Huan Yao, Huani Li, Huimin Huang	27
18	Protective effects of esculentic acid against endotoxic shock in Kunming mice 2014 ·International Immunopharmacology ·Xiaofeng Niu, Qingli Mu, Weifeng Li, Huan Yao, Huani Li, Yongmei Li, Hua Hu, Huimin Huang	7
19	The anti-inflammatory effects of sanguinarine and its modulation of inflammatory mediators from peritoneal macrophages 2012 ·European Journal of Pharmacology ·Xiaofeng Niu, Ting Fan, Weifeng Li, Xing Wei, Huimin Huang	108
20	Effects of chelerythrine, a specific inhibitor of cyclooxygenase-2, on acute inflammation in mice 2011 ·Fitoterapia ·Xiaofeng Niu, Ping Zhou, Weifeng Li, Hongbo Xu	53

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact